Susquehanna International Group, LLP Immatics N.V. Put Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$10.93 - $12.92 $1.53 Million - $1.81 Million	139,800 Added 117.28%	259,000 $2.96 Million
Q1 2024 May 07, 2024	BUY	$10.23 - $12.94 $362,142 - $458,076	35,400 Added 42.24%	119,200 $1.25 Million
Q4 2023 Feb 14, 2024	BUY	$7.36 - $10.89 $368,000 - $544,500	50,000 Added 147.93%	83,800 $882,000
Q3 2023 Nov 14, 2023	BUY	$11.01 - $12.62 $224,604 - $257,447	20,400 Added 152.24%	33,800 $391,000
Q2 2023 Aug 11, 2023	BUY	$5.92 - $12.72 $79,328 - $170,448	13,400 New	13,400 $154,000

101

75.8M

238K

727K

Ticker IMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,227,000
Market Cap $541M
Description
Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.